Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury

Liver Transplantation

Volumn 8, Issue 3, 2002, Pages 292-301

  Zekry, Amany ^a,b   Bishop, G Alex ^b   Bowen, David G ^a,b   Gleeson, Margaret M ^a   Guney, Seven ^a   Painter, Dorothy M ^c   McCaughan, Geoffrey W ^a,b  

^a AW Morrow Gastroenterology and Liver Centre   (Australia)

^b Liver Immunobiology Laboratory   (United States)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; METHYLPREDNISOLONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLOGRAFT; ARTICLE; ASSAY; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LIVER INJURY; LIVER SLICE; LIVER TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; REINFECTION; TH1 CELL; TH2 CELL; VIRUS LOAD; VIRUS REPLICATION;

EID: 0036199339     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2002.31655     Document Type: Article

References (55)

1. Long-term outcome of hepatitis C infection after liver transplantation
2. A longitudinal analysis of hepatitis C virus replication following liver transplantation
3. Viral dynamics of hepatitis C early after orthotopic liver transplantation: Evidence for rapid turnover of serum virions
4. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
5. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection
6. Analysis of successful immune responses in persons infected with hepatitis C virus
7. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines
8. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection
9. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections
10. Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C
11. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection
12. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation
13. Immunopathogenesis of hepatitis B and hepatitis C infection in the non-immunosuppressed and immunosuppressed state
14. Cholestatic hepatitis C in liver allografts
15. Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels
16. Post-transplant quasispecies pattern remains stable over time in patients with recurrent cholestatic hepatitis due to hepatitis C virus
17. Spontaneous clearance of hepatitis C virus infection post-liver transplantation is associated with rapidly changing quasispecies: A single case report
18. Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation
19. Posttransplant hepatitis C virus quasispecies and cholestatic hepatitis
20. Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation
21. Hepatitis C viral infection in liver transplant recipients
22. Hepatitis C in liver allografts
23. Impact of immunosuppression and acute rejection on recurrence of hepatitis C
24. Increased expression of interleukin-4 during liver allograft rejection
25. Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts
26. Differential gene expression patterns in HCV infected allografts during acute cellular rejection
27. Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation
28. The nomenclature of chronic hepatitis: Time for a change
29. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection
30. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation
31. Banff schema for grading liver allograft rejection: An international consensus document
32. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
33. Intragraft cytokine mRNA levels in human liver allograft rejection analysed by reverse transcription and semiquantitative polymerase chain reaction amplification
34. Quantitative reverse transcriptase-PCR amplification of cytokine mRNA in liver biopsy specimens using a non-competitive method
35. A novel method for real time quantitative RT-PCR
36. Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood
37. A human whole-blood assay for analysis of T-cell function by quantification of cytokine mRNA
38. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor m-RNA expression with fluorogenic probes or SYBR Green I
39. High levels of hepatitis C virus RNA in native livers correlate with the development of cholestatic hepatitis in liver allografts and a poor outcome
40. Quantitation of hepatitis C virus RNA in liver tissue of allografts: Correlation with histologic features and liver function tests
41. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders
42. Long-term use of recombinant interleukin 10 in patients with advanced chronic hepatitis C: Insight into immunopathogenesis
43. Inhibition of Th1 immune response by glucocorticoids: Dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes
44. Glucocorticoids induce a Th2 response in vitro
45. + T cells in vitro
46. Inhibition of interleukin 2 receptor expression in normal human T cells by cyclosporine. Demonstration at the mRNA, protein, and functional levels
47. IL-4 bypasses the immune suppressive effect of cyclosporin A during the in vitro induction of murine cytotoxic T lymphocytes
48. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: Association with treatment of rejection
49. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation
50. Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: The role of different immunosuppressive regimens
51. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses
52. Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level
53. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation
54. Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation
55. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin